Cargando…

Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study

Detalles Bibliográficos
Autores principales: Zhang, Xian-Wen, Liu, Xiao-Xia, Yong, Jun, Wei, Li-Feng, Ling, Chun-Yan, Jin, Yu, Chen, Yi-Ping, Wang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478391/
https://www.ncbi.nlm.nih.gov/pubmed/34553703
http://dx.doi.org/10.1097/CM9.0000000000001565
_version_ 1784576046200258560
author Zhang, Xian-Wen
Liu, Xiao-Xia
Yong, Jun
Wei, Li-Feng
Ling, Chun-Yan
Jin, Yu
Chen, Yi-Ping
Wang, Lin
author_facet Zhang, Xian-Wen
Liu, Xiao-Xia
Yong, Jun
Wei, Li-Feng
Ling, Chun-Yan
Jin, Yu
Chen, Yi-Ping
Wang, Lin
author_sort Zhang, Xian-Wen
collection PubMed
description
format Online
Article
Text
id pubmed-8478391
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-84783912021-09-30 Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study Zhang, Xian-Wen Liu, Xiao-Xia Yong, Jun Wei, Li-Feng Ling, Chun-Yan Jin, Yu Chen, Yi-Ping Wang, Lin Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2021-09-20 2021-06-24 /pmc/articles/PMC8478391/ /pubmed/34553703 http://dx.doi.org/10.1097/CM9.0000000000001565 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Zhang, Xian-Wen
Liu, Xiao-Xia
Yong, Jun
Wei, Li-Feng
Ling, Chun-Yan
Jin, Yu
Chen, Yi-Ping
Wang, Lin
Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study
title Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study
title_full Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study
title_fullStr Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study
title_full_unstemmed Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study
title_short Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study
title_sort association of anti-phospholipase a(2) receptor antibody with the efficacy of traditional chinese medicine (shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478391/
https://www.ncbi.nlm.nih.gov/pubmed/34553703
http://dx.doi.org/10.1097/CM9.0000000000001565
work_keys_str_mv AT zhangxianwen associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy
AT liuxiaoxia associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy
AT yongjun associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy
AT weilifeng associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy
AT lingchunyan associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy
AT jinyu associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy
AT chenyiping associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy
AT wanglin associationofantiphospholipasea2receptorantibodywiththeefficacyoftraditionalchinesemedicineshenqiparticleforpatientswithidiopathicmembranousnephropathyaprospectivecohortclinicalstudy